Patents by Inventor Pierre DODION

Pierre DODION has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF HEAD AND NECK CANCER
    Publication number: 20240117045
    Abstract: This invention relates to the use of NKG2A-targeting agents for the treatment of cancers, notably head and neck cancers, in a patient having received prior treatment with cetuximab. This invention also provides advantageous combination regimens for use with NKG2A-targeting agents for the treatment of cancers.
    Type: Application
    Filed: October 23, 2023
    Publication date: April 11, 2024
    Inventors: AGNÈS BOYER-CHAMMARD, PIERRE DODION, ROGER COHEN
  • Treatment of head and neck cancer
    Patent number: 11795222
    Abstract: This invention relates to the use of NKG2A-targeting agents for the treatment of cancers, notably head and neck cancers, in a patient having received prior treatment with cetuximab. This invention also provides advantageous combination regimens for use with NKG2A-targeting agents for the treatment of cancers.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: October 24, 2023
    Assignee: INNATE PHARMA
    Inventors: Agnes Boyer-Chammard, Pierre Dodion, Roger Cohen
  • TREATMENT OF HEAD AND NECK CANCER
    Publication number: 20210061909
    Abstract: This invention relates to the use of NKG2A-targeting agents for the treatment of cancers, notably head and neck cancers, in a patient having received prior treatment with cetuximab. This invention also provides advantageous combination regimens for use with NKG2A-targeting agents for the treatment of cancers.
    Type: Application
    Filed: March 12, 2019
    Publication date: March 4, 2021
    Applicant: Innate Pharma
    Inventors: Agnes BOYER-CHAMMARD, Pierre DODION, Roger COHEN